RESOURCES - PRESS RELEASES
RevTek Capital’s resources reflect our commitment to supporting innovative companies. Our experts provide professional guidance to navigate the funding process efficiently to build value and growth.
Press Releases
QUANTUM5 Closes Third Financing Round with RevTek Capital
Quantum⁵, enters an exciting new chapter of growth with a third round of financing from RevTek Capital, a funding provider for innovative and growing companies. Quantum⁵, a leader in automotive dealership training, is significantly extending its reach and expanding its solutions offerings across the U.S.
Coreware Closes a Strategic Financing Round with RevTek Capital
Coreware has successfully closed a financing deal with RevTek Capital, marking a significant step in its mission to drive innovation and expand its market presence. This partnership is set to bolster Coreware’s capabilities and accelerate its growth trajectory in the competitive tech landscape.
Previon Closes a Strategic Financing Round with RevTek Capital
Previon has successfully closed a financing deal with RevTek Capital, marking a significant step in its mission to drive innovation and growth in the tech sector. This partnership aims to bolster Previon’s capabilities and expand its market reach.
Cymbiotika Secures $30 Million in Debt Financing to Strengthen Growth and Expansion
Cymbiotika has successfully secured $30 million in debt financing from RevTek Capital, a leading provider of strategic capital for high-growth companies. This financing will enable Cymbiotika to expand into retail, enter the Canadian market, and enhance infrastructure to support its growing operations. The collaboration with RevTek Capital will also drive product innovation and increase operational efficiency. This investment is expected to accelerate the company’s growth trajectory, both in revenue and EBITDA, in the coming years. RevTek Capital offers funding opportunities ranging from $2 million to $20 million+ for companies with predictable recurring revenue, helping businesses like Cymbiotika achieve their long-term goals.
Paxera Health Closes Financing Round with RevTek Capital
Paxera Health, a leader in AI medical imaging, announces a successful financing round with RevTek Capital to accelerate growth and enhance healthcare solutions. This partnership will enable Paxera to further automate workflows and improve patient care, driving advancements in clinical outcomes for healthcare providers.
QUANTUM5 Closes Financing Round with RevTek Capital
Quantum⁵, enters an exciting new chapter of growth with financing from RevTek Capital, a funding provider for innovative and growing companies. Quantum⁵, a leader in automotive dealership training, is significantly extending its reach and expanding its solutions offerings across the U.S.
Roambee Unveils the World’s First True 5G GPS Smart Label for Unrestricted Shipment Visibility
Santa Clara, CA — In a groundbreaking development for the logistics industry, Roambee introduces the world’s first true 5G GPS ‘peel-and-ship’ smart label, rapidly embraced by leading Global 2000 brands.
The collaboration between innovation and financing support from RevTek Capital underscores the accomplishments possible when innovative companies thrive with needed growth capital.
Cloud Dentistry Closes Financing Round with RevTek Capital
Cloud Dentistry, the largest network of dental professionals actively seeking permanent and temporary work, is entering an exciting new chapter of growth with financing from RevTek Capital, a leading capital provider for innovative and growing companies.
Popular Articles more...
Fintech Studios™ Closes Fifth Financing Round with RevTek Capital
FinTech Studios™, a leader in AI-driven market intelligence for financial institutions, has closed its fifth financing round with RevTek Capital. The funding will accelerate global expansion and empower FinTech Studios™ to grow
Newsletter – Jan ’24
Newsletter Jan ’24
Many exciting things already underway in this new year. Off to a big start with very high expectations for growth. Of course we keep an eye on the
Apex Biologix Closes a Strategic Financing Round with RevTek Capital
Apex Biologix, a pioneer in regenerative medicine, has closed a strategic financing round with RevTek Capital to support its rapid growth and expand its suite of FDA-cleared solutions, including the groundbreaking XCELL
SaaS Marketing Strategies: 2024
Until the recent past, business and marketing models have been built around companies trying to sell a physical product. They want you to buy the newest car, the best watch, or even
We devote the time to understand your accomplishments, circumstances, and opportunities to create a customized debt funding structure to accelerate your growth.
